These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 650992

  • 1. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S.
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T, Sumie A, Ishii T, Tomo T, Magari Y, Sato J, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 8. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 9. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H, Matsunaga K, Taira K, Nakajima M, Whitworth JA, Kincaid-Smith P.
    Clin Nephrol; 1988 Mar 12; 29(3):124-8. PubMed ID: 3359703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y.
    Nihon Jinzo Gakkai Shi; 1976 Jun 12; 18(6):371-87. PubMed ID: 988340
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD, Terry JM.
    Clin Nephrol; 1979 Mar 12; 11(3):140-1. PubMed ID: 436342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Mar 12; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 20. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M.
    Clin Nephrol; 1995 Aug 12; 44(2):91-5. PubMed ID: 8529315
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.